349 related articles for article (PubMed ID: 30584954)
1. Development, validation and integration of in silico models to identify androgen active chemicals.
Manganelli S; Roncaglioni A; Mansouri K; Judson RS; Benfenati E; Manganaro A; Ruiz P
Chemosphere; 2019 Apr; 220():204-215. PubMed ID: 30584954
[TBL] [Abstract][Full Text] [Related]
2. CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity.
Mansouri K; Kleinstreuer N; Abdelaziz AM; Alberga D; Alves VM; Andersson PL; Andrade CH; Bai F; Balabin I; Ballabio D; Benfenati E; Bhhatarai B; Boyer S; Chen J; Consonni V; Farag S; Fourches D; García-Sosa AT; Gramatica P; Grisoni F; Grulke CM; Hong H; Horvath D; Hu X; Huang R; Jeliazkova N; Li J; Li X; Liu H; Manganelli S; Mangiatordi GF; Maran U; Marcou G; Martin T; Muratov E; Nguyen DT; Nicolotti O; Nikolov NG; Norinder U; Papa E; Petitjean M; Piir G; Pogodin P; Poroikov V; Qiao X; Richard AM; Roncaglioni A; Ruiz P; Rupakheti C; Sakkiah S; Sangion A; Schramm KW; Selvaraj C; Shah I; Sild S; Sun L; Taboureau O; Tang Y; Tetko IV; Todeschini R; Tong W; Trisciuzzi D; Tropsha A; Van Den Driessche G; Varnek A; Wang Z; Wedebye EB; Williams AJ; Xie H; Zakharov AV; Zheng Z; Judson RS
Environ Health Perspect; 2020 Feb; 128(2):27002. PubMed ID: 32074470
[TBL] [Abstract][Full Text] [Related]
3. Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals.
Rotroff DM; Dix DJ; Houck KA; Knudsen TB; Martin MT; McLaurin KW; Reif DM; Crofton KM; Singh AV; Xia M; Huang R; Judson RS
Environ Health Perspect; 2013 Jan; 121(1):7-14. PubMed ID: 23052129
[TBL] [Abstract][Full Text] [Related]
4. Integration of in silico methods and computational systems biology to explore endocrine-disrupting chemical binding with nuclear hormone receptors.
Ruiz P; Sack A; Wampole M; Bobst S; Vracko M
Chemosphere; 2017 Jul; 178():99-109. PubMed ID: 28319747
[TBL] [Abstract][Full Text] [Related]
5. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.
Zhang L; Sedykh A; Tripathi A; Zhu H; Afantitis A; Mouchlis VD; Melagraki G; Rusyn I; Tropsha A
Toxicol Appl Pharmacol; 2013 Oct; 272(1):67-76. PubMed ID: 23707773
[TBL] [Abstract][Full Text] [Related]
6. Computational models to predict endocrine-disrupting chemical binding with androgen or oestrogen receptors.
Chen Y; Cheng F; Sun L; Li W; Liu G; Tang Y
Ecotoxicol Environ Saf; 2014 Dec; 110():280-7. PubMed ID: 25282305
[TBL] [Abstract][Full Text] [Related]
7. Weight of evidence for cross-species conservation of androgen receptor-based biological activity.
Vliet SMF; Markey KJ; Lynn SG; Adetona A; Fallacara D; Ceger P; Choksi N; Karmaus AL; Watson A; Ewans A; Daniel AB; Hamm J; Vitense K; Wolf KA; Thomas A; LaLone CA
Toxicol Sci; 2023 May; 193(2):131-145. PubMed ID: 37071731
[TBL] [Abstract][Full Text] [Related]
8. A novel framework for interpretation of data from the fish short-term reproduction assay (FSTRA) for the detection of endocrine-disrupting chemicals.
Ankley GT; Jensen KM
Environ Toxicol Chem; 2014 Nov; 33(11):2529-40. PubMed ID: 25098918
[TBL] [Abstract][Full Text] [Related]
9. Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model.
Browne P; Judson RS; Casey WM; Kleinstreuer NC; Thomas RS
Environ Sci Technol; 2015 Jul; 49(14):8804-14. PubMed ID: 26066997
[TBL] [Abstract][Full Text] [Related]
10. Machine Learning Consensus To Predict the Binding to the Androgen Receptor within the CoMPARA Project.
Grisoni F; Consonni V; Ballabio D
J Chem Inf Model; 2019 May; 59(5):1839-1848. PubMed ID: 30668916
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Computational Model for Androgen Receptor Activity.
Kleinstreuer NC; Ceger P; Watt ED; Martin M; Houck K; Browne P; Thomas RS; Casey WM; Dix DJ; Allen D; Sakamuru S; Xia M; Huang R; Judson R
Chem Res Toxicol; 2017 Apr; 30(4):946-964. PubMed ID: 27933809
[TBL] [Abstract][Full Text] [Related]
12. Assessing utility of thyroid in vitro screening assays through comparisons to observed impacts in vivo.
Eytcheson SA; Olker JH; Friedman KP; Hornung MW; Degitz SJ
Regul Toxicol Pharmacol; 2023 Oct; 144():105491. PubMed ID: 37666444
[TBL] [Abstract][Full Text] [Related]
13. Endocrine profiling and prioritization of environmental chemicals using ToxCast data.
Reif DM; Martin MT; Tan SW; Houck KA; Judson RS; Richard AM; Knudsen TB; Dix DJ; Kavlock RJ
Environ Health Perspect; 2010 Dec; 118(12):1714-20. PubMed ID: 20826373
[TBL] [Abstract][Full Text] [Related]
14. CERAPP: Collaborative Estrogen Receptor Activity Prediction Project.
Mansouri K; Abdelaziz A; Rybacka A; Roncaglioni A; Tropsha A; Varnek A; Zakharov A; Worth A; Richard AM; Grulke CM; Trisciuzzi D; Fourches D; Horvath D; Benfenati E; Muratov E; Wedebye EB; Grisoni F; Mangiatordi GF; Incisivo GM; Hong H; Ng HW; Tetko IV; Balabin I; Kancherla J; Shen J; Burton J; Nicklaus M; Cassotti M; Nikolov NG; Nicolotti O; Andersson PL; Zang Q; Politi R; Beger RD; Todeschini R; Huang R; Farag S; Rosenberg SA; Slavov S; Hu X; Judson RS
Environ Health Perspect; 2016 Jul; 124(7):1023-33. PubMed ID: 26908244
[TBL] [Abstract][Full Text] [Related]
15. Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods.
Zang Q; Rotroff DM; Judson RS
J Chem Inf Model; 2013 Dec; 53(12):3244-61. PubMed ID: 24279462
[TBL] [Abstract][Full Text] [Related]
16. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
LeBaron MJ; Coady KK; O'Connor JC; Nabb DL; Markell LK; Snajdr S; Sue Marty M
Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Estrogenic Bioactivity of Environmental Chemical Metabolites.
Pinto CL; Mansouri K; Judson R; Browne P
Chem Res Toxicol; 2016 Sep; 29(9):1410-27. PubMed ID: 27509301
[TBL] [Abstract][Full Text] [Related]
18. On selecting a minimal set of in vitro assays to reliably determine estrogen agonist activity.
Judson RS; Houck KA; Watt ED; Thomas RS
Regul Toxicol Pharmacol; 2017 Dec; 91():39-49. PubMed ID: 28993267
[TBL] [Abstract][Full Text] [Related]
19. A Mechanistic High-Content Analysis Assay Using a Chimeric Androgen Receptor That Rapidly Characterizes Androgenic Chemicals.
Szafran AT; Bolt MJ; Obkirchner CE; Mancini MG; Helsen C; Claessens F; Stossi F; Mancini MA
SLAS Discov; 2020 Aug; 25(7):695-708. PubMed ID: 32392092
[TBL] [Abstract][Full Text] [Related]
20. Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II.
Filer D; Patisaul HB; Schug T; Reif D; Thayer K
Curr Opin Pharmacol; 2014 Dec; 19():145-52. PubMed ID: 25460227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]